Air Products, Airgas Continue Wrangling Over Poison Pill
January 26 2011 - 5:49PM
Dow Jones News
Airgas Inc. (ARG) Wednesday maintained it is worth markedly
higher than the $70-a-share "best and final" offer from hostile
rival Air Products & Chemicals Inc. (APD), while Air Products
continued to argue the Airgas poison pill unfairly prevents Airgas
shareholders from deciding for themselves.
Wednesday's testimony in Delaware's Court of Chancery marked day
two of what's expected to be a three-day trial to decide Air
Products' challenge of the Airgas pill, or shareholder-rights plan,
which effectively prevents Air Products from consummating its
tender offer. The judge in the case has indicated his ruling will
come soon after the trial ends, and observers aren't ruling out a
decision Thursday.
Delaware has mostly upheld challenges to pills since they came
into wide usage in the 1980s, and the ultimate result of this trial
will have broad implications in how targets defend against unwanted
takeovers and how would-be acquirers attempt to defeat those
defenses.
Investment banker David A. DeNunzio of Credit Suisse in
testimony predicted Airgas shares would surpass the Air Products
offer price by next year, thanks to continued earnings improvement.
The Radnor, Pa. company's stock could be worth from the mid-$70s to
mid-$80s, he told Chancellor William Chandler.
Credit Suisse is the most recent of three investment banks
retained by Airgas, whose independent views all support Airgas's
contention that it's worth at least $78 a share in a takeover. That
view is based on a standalone value for Airgas in the low $60s plus
a reasonable premium that would be customary in a strategic
acquisition.
Air Products says Airgas leaders are unreasonably keeping the
pill in place, even though they know a majority of shareholders
would take the $70 offer. The pill has warded off the hostile
tender for more than a year. That's long enough, Air Products
argues.
Airgas doesn't dispute that holders would tender more than half
the company's shares into the Air Products offer, but feels the
price is nonetheless inadequate and the acceptance would be driven
by merger arbitrageurs. The Airgas board maintains fiduciary duty
compels it to keep the question from going to the shareholders.
Arbitrageurs are short-term investors, uninterested in a proper
valuation and simply motivated by securing a deal in short order,
Airgas contends. Arbitrageurs began piling into Airgas stock after
Air Products made its initial offer public last February, and their
collective ownership was recently 41% of the stock, Airgas Chief
Executive Peter McCausland testified Tuesday, down from as high as
55% previously as the certainty of a deal has waned in recent
weeks.
Air Products Chief Executive John McGlade said Tuesday that a
loss in court means the company is "moving on and pursuing our
other alternatives."
"We weren't talking nickels and quarters here," Credit Suisse's
DeNunzio said, commenting on the spread between what he thinks
Airgas is worth and the price Air Products says it's willing to
pay. "We had pretty easily concluded that the $70 a share was
inadequate."
John Clancey, who joined the Airgas board in September after
being put up for election by Air Products, said Airgas stock, "if
and when this is behind us, will be trading in the $70s." Clancey
also intimated that Air Products, of Lehigh Valley, Pa., could
boost its offer for Air Gas.
"We play 'best and final.' Our customers play 'best and final,'"
Clancey said. "'Best and final' is normally a cliche that gets you
into the finals so that you can take your price up or take your
price down."
Airgas stock closed down fractionally at $61.97, a signal
investors believe Airgas will succeed in fending off Air
Products.
"Now is not the right time to sell," Clancey said.
Chancellor Chandler questioned witnesses about the readiness of
Airgas shareholders to evaluate Air Products' tender offer. One
justification for corporate defenses is that they allow
shareholders time to gather and weigh information.
"I think you'd have to conclude that this shareholder base is
well informed," DeNunzio said.
-By Peg Brickley, Dow Jones Newswires; 215-462-0593;
peg.brickley@dowjones.com, and Maxwell Murphy, Dow Jones Newswires;
212-416-2171; maxwell.murphy@dowjones.com
Air Products and Chemicals (NYSE:APD)
Historical Stock Chart
From May 2024 to Jun 2024
Air Products and Chemicals (NYSE:APD)
Historical Stock Chart
From Jun 2023 to Jun 2024